| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/12/2001 | WO2001025393A1 Elastic article |
| 04/12/2001 | WO2001025390A2 Water unstable foam compositions |
| 04/12/2001 | WO2001025295A1 Crosslinked copolymers based on non-crosslinked polycarboxylic copolymers |
| 04/12/2001 | WO2001025213A2 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | WO2001025209A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/12/2001 | WO2001025208A1 Pyridinium derivatives for the management of aging-related and diabetic vascular complications, process for their preparation and therapeutic uses thereof |
| 04/12/2001 | WO2001025198A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 04/12/2001 | WO2001024990A1 Process for preparing a foam component |
| 04/12/2001 | WO2001024918A1 Device and method for producing halogens with a modified action |
| 04/12/2001 | WO2001024917A1 Method and apparatus for obtaining a suspension of particles |
| 04/12/2001 | WO2001024842A2 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | WO2001024839A1 Silver-containing compositions, devices and methods for making |
| 04/12/2001 | WO2001024817A2 Pharmaceutical compositions of fibrinolytic agent |
| 04/12/2001 | WO2001024814A1 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/12/2001 | WO2001024807A2 Method for calming human beings using personal care compositions |
| 04/12/2001 | WO2001024804A2 Method for preparing a composition by mother-of-pearl extraction, and use thereof in cosmetics and dermatology |
| 04/12/2001 | WO2001024801A1 Pharmaceutical formulations containing poorly soluble drug substances |
| 04/12/2001 | WO2001024795A1 RETARD FORM CONTAINING α-LIPOIC ACID (DERIVATIVES) |
| 04/12/2001 | WO2001024793A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | WO2001024788A2 Treating endometriosis or infertility, or improving fertility |
| 04/12/2001 | WO2001024780A2 Soft gel capsule resistant to gastric juices |
| 04/12/2001 | WO2001024778A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | WO2001024777A1 Coated solid dosage forms |
| 04/12/2001 | WO2001024776A1 Biodegradable excipient systems for therapeutically active substances and method for producing the same |
| 04/12/2001 | WO2001024774A1 Ortho ester lipids |
| 04/12/2001 | WO2001024773A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | WO2001024772A1 Formulation for menopausal women |
| 04/12/2001 | WO2001024771A1 Composition and method of cancer antigen immunotherapy |
| 04/12/2001 | WO2001024762A2 Method for improving uv radiation stability of photosensitive sunscreen filters |
| 04/12/2001 | WO2001024705A1 Improved methods for delivering bioactive agents |
| 04/12/2001 | WO2001006982A3 Low-dose tablets and preparation method |
| 04/12/2001 | WO2001000230A8 Drug composition containing lecithin-modified superoxide dismutase |
| 04/12/2001 | WO2000074655A9 Delayed total release two pulse gastrointestinal drug delivery system |
| 04/12/2001 | WO2000048582A3 Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence |
| 04/12/2001 | WO2000047192A3 UBIQUINONE QnFOR THE TREATMENT OF PAINS |
| 04/12/2001 | WO2000006296A3 Microparticles produced from cyclic olefin copolymers and their use for the controlled release of active agents |
| 04/12/2001 | WO2000004891A3 Anti-ulcer composition |
| 04/12/2001 | US20010000230 Matrices formed of polymer and hydrophobic compounds for use in drug delivery |
| 04/12/2001 | DE19949043A1 Suppositories used for treating acute and chronic pain contain tramadol and diclofenac |
| 04/12/2001 | CA2645397A1 Formulation for menopausal women |
| 04/12/2001 | CA2388864A1 Ortho ester lipids |
| 04/12/2001 | CA2387703A1 Method for calming human beings using personal care compositions |
| 04/12/2001 | CA2387288A1 Anti-inflammatory pharmaceutical formulations |
| 04/12/2001 | CA2386820A1 Removal of dye-labeled dideoxy terminators from dna sequencing reactions |
| 04/12/2001 | CA2386795A1 Pyrrolo imidazole derivatives and their use as medicaments |
| 04/12/2001 | CA2386461A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion |
| 04/12/2001 | CA2386373A1 Method for improving the solubility of tricyclic amino alcohol derivatives |
| 04/12/2001 | CA2386277A1 An improved pharmaceutical composition and a process for its preparation |
| 04/12/2001 | CA2386228A1 Stabilized liquid pharmaceutical compositions comprising tissue factor pathway inhibitor (tfpi) polypeptides |
| 04/12/2001 | CA2386024A1 Liposome-entrapped dna oral vaccines |
| 04/12/2001 | CA2385966A1 Pharmaceutical compositions of fibrinolytic agent |
| 04/12/2001 | CA2385696A1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 04/12/2001 | CA2385313A1 Foams and compositions containing these foams |
| 04/12/2001 | CA2385213A1 Elastic article |
| 04/12/2001 | CA2385195A1 Process for preparing a foam component |
| 04/12/2001 | CA2383306A1 Novel pharmaceutical compositions |
| 04/12/2001 | CA2379971A1 Hybrid matrices and hybrid matrix mixtures |
| 04/12/2001 | CA2353718A1 Method for improving uv radiation stability of photosensitive sunscreen filters |
| 04/12/2001 | CA2351075A1 Pyridinium derivatives for the treatment of diabetic and aging-related vascular complications |
| 04/11/2001 | EP1090928A1 Polymers loaded with bioactive agents |
| 04/11/2001 | EP1090919A1 Fine powder of l-alpha-aminoadipic acid derivative, oral solid preparations containing the same, and method for treatment of bulk powders |
| 04/11/2001 | EP1090637A2 Compositions and methods for treating or preventing inflammatory diseases |
| 04/11/2001 | EP1090635A2 Use of ferulic acid for treating hypertension |
| 04/11/2001 | EP1089996A1 Paroxetine methanesulfonate |
| 04/11/2001 | EP1089970A2 Oxidation inhibitors for prostane derivatives |
| 04/11/2001 | EP1089872A1 Multi-action particle for structuring biological media |
| 04/11/2001 | EP1089785A1 Method, implant and delivery system for enhancing blood flow in tissue |
| 04/11/2001 | EP1089754A2 An antimicrobial effective against gram-positive pathogens |
| 04/11/2001 | EP1089746A1 Extracts of hypericum perforatum and formulations containing them |
| 04/11/2001 | EP1089745A1 Oregano for the treatment of internal parasites and protozoa |
| 04/11/2001 | EP1089739A1 Cyclophosphamide coated tablets |
| 04/11/2001 | EP1089734A2 Use of tempo and tempo derivatives for inducing cell death |
| 04/11/2001 | EP1089727A1 Liposomal formulations of busulphan |
| 04/11/2001 | EP1089722A1 Matrix-type transdermal patch for steroid hormones |
| 04/11/2001 | EP1089721A1 Pharmaceutical product and methods and apparatus for making same |
| 04/11/2001 | EP1089720A1 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2001 | EP1089719A2 Transdermal therapeutic system containing hormones and crystallization inhibitors |
| 04/11/2001 | EP1089718A1 Sticking plaster for controlled release of natural interferon |
| 04/11/2001 | EP1089717A2 Chewable oral unit dosage |
| 04/11/2001 | EP1089716A1 Ingestible elements |
| 04/11/2001 | EP1089715A1 Aqueous compositions containing corticosteroids for nasal and pulmonary delivery |
| 04/11/2001 | EP1089714A2 Processes to generate submicron particles of water-insoluble compounds |
| 04/11/2001 | EP1089713A1 Temperature-sensitive liposomal formulation |
| 04/11/2001 | EP1089712A2 Large porous particles emitted from an inhaler |
| 04/11/2001 | EP1089711A1 Calcium phosphate coated vesicles |
| 04/11/2001 | EP1089710A1 Injectable pharmaceutical formulations of partricin derivatives |
| 04/11/2001 | EP1089709A1 Icecream-type pharmaceutical formulation and process for preparing the same |
| 04/11/2001 | EP1089686A1 Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity |
| 04/11/2001 | EP1089679A1 A device and method for the treatment of erectile dysfunction |
| 04/11/2001 | EP1089620A1 Hydrophilic polymer blends used to prevent cow skin infections |
| 04/11/2001 | EP0918498A4 Improved tissue injectable composition and method of use |
| 04/11/2001 | EP0810856B1 Banded prolonged release active agent dosage form |
| 04/11/2001 | EP0750506B1 Broad spectrum antimicrobial compounds and methods of use |
| 04/11/2001 | EP0517829B1 Improved chimeric toxins |
| 04/11/2001 | CN1291196A Nevol anti-estrogenic steroids, and associated pharmaceutical compositions and method of use |
| 04/11/2001 | CN1291107A Skin cave compositions |
| 04/11/2001 | CN1291101A Regulation of estrus and ovulation in gilts |
| 04/11/2001 | CN1291098A Oral liquid formulations of benzoxazinones HIV reverse transcriptase inhibitors |
| 04/11/2001 | CN1291097A Morphine sulphate microgranules, method for making same and pharmaceutical preparations |
| 04/11/2001 | CN1291093A Pig appeasing pheromones to decrease stress, anxiety and aggressiveness |